default author photo

Areej A. Malhani

King Fahad Medical City - Clinical Pharmacy Department

Riyadh

Saudi Arabia

SCHOLARLY PAPERS

1

DOWNLOADS

39

TOTAL CITATIONS

2

Scholarly Papers (1)

1.

Combination of (Interferon beta-1b, Lopinavir-Ritonavir and Ribavirin) versus Favipiravir in Hospitalized Patients with Non-Critical COVID-19: A Cohort Study

Number of pages: 34 Posted: 17 Mar 2021
King Fahad Medical City - Clinical Pharmacy Department, King Fahad Medical City - Infectious Diseases Section, University of Sharjah - Sharjah Institute of Medical Research, King Fahad Medical City - Clinical Research Coordinator, King Fahad Medical City - Clinical Research Coordinator, King Fahad Medical City - Outpatient Pharmacy Department, University of Sharjah - Sharjah Institute of Medical Research and King Fahad Medical City - Infectious Diseases Section
Downloads 39 (1,195,764)
Citation 2

Abstract:

Loading...

Interferon-B 1b, Triple therapy, Lopinavir-ritonavir, Ribavirin, Favipiravir, COVID-19, 28-days mortality